wineberry
16 Mar 2015
Another drug company Having come to the market in December 2014, its share price has suddenly taken off, and there is a recent positive news release on trading in both main divisions, particularly the approval and launch of its first licensed medicine with others being submitted for approval. Worth a look - possible potential here but DYOR as always
